# BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
> **ANDA202584** · Abbreviated New Drug Application (Generic) · Sponsor: AILEX PHARMS LLC · Approved 2018-11-30
## Drug
- **FDA Application Number:** ANDA202584
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
- **Generic name:** Bismuth Subsalicylate
- **Active ingredients:** BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
- **Dosage form:** TABLET, CHEWABLE, TABLET, CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AILEX PHARMS LLC
- **First approval:** 2018-11-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202584)
---
*MORVS · CC0 1.0*